PIK3CA and neoplasm: The phosphoinositide 3-kinase (PI3K) pathway is commonly activated in many cancer types, including EC, frequently due to mutations at multiple nodes, for example PIK3CA (which encodes the p110α catalytic subunit of PI3K), or loss of PTEN protein expression (the major tumour suppressor that regulates this pathway).